---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-017562"
form_type: "8-K"
ticker: "MLSS"
cik: "0000855683"
company_name: "MILESTONE SCIENTIFIC INC."
filed_at: "2025-05-19T23:59:59+00:00"
generated_at: "2026-05-21T02:35:05.029592+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Milestone Scientific appoints Shanth Thiyagalingam as independent director

## Summary
- Appointed on May 14, 2025 as an independent director; fills Board vacancy.
- Thiyagalingam is CEO of PainTEQ, a medical device maker, with prior roles at Abbott, Nevro, Stryker, and St. Jude Medical.
- Brings medical device industry and commercial leadership experience to the Board.

## SEC filing metadata
- accession: 0001437749-25-017562
- form_type: 8-K
- ticker: MLSS
- cik: 0000855683
- company_name: MILESTONE SCIENTIFIC INC.
- filed_at: 2025-05-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/855683/000143774925017562/0001437749-25-017562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/855683/000143774925017562/mlss20250519_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-017562
- JSON: https://secwatch.observer/filing/0001437749-25-017562.json
- Plain text: https://secwatch.observer/filing/0001437749-25-017562.txt

## Key facts
- Executive change
  Shanth Thiyagalingam was appointed as independent director at MILESTONE SCIENTIFIC INC..
  - Action: appointed
  - Role: independent director
  source text: On May 14, 2025, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Shanth Thiyagalingam as an independent director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/855683/000143774925017562/0001437749-25-017562-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.